Evidence map›Paper›PMID 40346963›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Filamented Light (FLight) Biofabrication of Aligned Fibrillar Structures to Direct 3D Cell Organization Within Microgels.

Akshat Joshi, Meenakshi Kamaraj, Nafiseh Moghimi, Hossein Heidari, Arwin Aghamaleky-Sarvestany, Chethikkattuveli Salih Abdul Rahim, Diego N Rodriguez-Sanchez, Caroline Hu, Sree Aravindan, Deepthi S Rajendran Nair and 7 more

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Akshat JoshiTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
Meenakshi KamarajTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
Nafiseh MoghimiTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
Hossein HeidariTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
Arwin Aghamaleky-SarvestanyCedars-Sinai Biomanufacturing Center, West Hollywood, CA, 90069, USA.
Chethikkattuveli Salih Abdul RahimTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
Diego N Rodriguez-SanchezTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
Caroline HuCenter for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
Sree AravindanCenter for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
Deepthi S Rajendran NairDepartment of Ophthalmology, Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
Ngan F HuangDepartment of Cardiothoracic Surgery, Stanford University and Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, 94304, USA.
Biju B ThomasDepartment of Ophthalmology, Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
Dhruv SareenCedars-Sinai Biomanufacturing Center, West Hollywood, CA, 90069, USA.
Eiji YoshiharaThe Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, 90502, USA.
Vadim JucaudTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
Ali KhademhosseiniTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.
Johnson V JohnTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90024, USA.ORCID 0000-0001-8105-0808

Funding

Ophthalmic Therapeutics Engineering CoreP30EY029220 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Mahnaz Shahidi · 2018 to 2026
$6.5M
Engineering the open porous nanofibrous microsphere integrated fibrillar hydrogel for the co-delivery of antibacterial and angiogenic agents aimed at the rapid diabetic wound repairR01DK134903 · NIDDK · TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION · PI Johnson Vitharikunnil John · 2023 to 2026
$2.2M
Spatiotemporal regulation of human islet organogenesisR01DK136888 · NIDDK · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI Eiji Yoshihara · 2024 to 2026
$1.8M
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cellsR01HL142718 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, HUANG, NGAN F. · 2018 to 2021
$1.6M
Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Peripheral Artery DiseaseR41HL170875 · NHLBI · SERINA THERAPEUTICS, INC. · PI HUANG, NGAN F., LEE, JI EUN · 2023 to 2023
$341k
BrightFocus Foundation M2016186Cedars-Sinai Programmatic FundsMedical Technology Enterprise Consortium MTEC 20-07-QualRegen-010NEI NIH HHS P30 EY029220NHLBI NIH HHS R01 HL142718NHLBI NIH HHS R21 HL172096-01NHLBI NIH HHS R41 HL170875NIDDK NIH HHS R01 DK134903NIDDK NIH HHS R01DK134903NIDDK NIH HHS R01 DK136888UCI Department of OphthalmologyUS Army Medical Research and Development Command USMRDCUS Department of Veterans Affairs 1I01BX004259US Department of Veterans Affairs 1I21RX004898US Department of Veterans Affairs 5I01RX001222
6 · The paper itself

Abstract

Controlling cellular organization in hydrogels is of great interest in tissue engineering and regenerative medicine. In the body, cell organization is regulated by aligned extracellular matrices, such as collagen fibers. However, generating patterned extracellular matrix fibers in hydrogels, such as microfabricated gels, is not easily accomplished. Here, filamented-light (FLight)-based 3D microfabrication is used to fabricate microgels with precise internal architecture to direct cellular organization. It is demonstrated that fibrillated rod-shaped microgels encapsulating C2C12 muscle cells promote highly aligned myotube formation, offering potential as mini-injectable muscle tissues for minimally invasive muscle loss therapies. Furthermore, photoreceptor cells encapsulated in rod-shaped microgels generated structures that mimicked the outer retina. Moreover, these microgels can be used as injectable scaffolds, both in vitro and in vivo, where they facilitate angiogenesis when conjugated with QK peptide. Overall, this technique can be used to generate microgels with precise internal architecture thus providing a potentially significant tool for engineering tissue-like structures.

Indexed as

LightMicrogelsTissue EngineeringAnimalsCell LineExtracellular MatrixHydrogelsMiceTissue ScaffoldsHydrogelsMicrogelsbioprintingcellular organizationlight‐based microfabricationtissue engineering

Identifiers

PMID40346963
PMCPMC13215041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.